Management of Fragments During Ureteroscopy

Sponsor
The Chaim Sheba Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00637650
Collaborator
(none)
1
2
11

Study Details

Study Description

Brief Summary

The purpose of this study is to study the outcome of patients after ureteroscopy in which all fragments remaining after holmium laser lithotripsy were retrieved compared to those where small, insignificant fragments were left for spontaneous passage.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ureteroscopy, Holmium Laser lithotripsy and active retrieval of fragments
  • Procedure: Ureteroscopy, Holmium laser lithotripsy, no intent to retrieve any remaining fragment
N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Should we Strive for Absolute "Stone Freedom" While Performing Holmium Laser Lithotripsy for Ureteral Stones? A Randomized Controlled Trial.
Study Start Date :
Jun 1, 2007
Actual Primary Completion Date :
Apr 1, 2008
Actual Study Completion Date :
May 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: B

Experimental group: patients in whom "stone dust" was left for spontaneous elimination

Procedure: Ureteroscopy, Holmium laser lithotripsy, no intent to retrieve any remaining fragment

Other: A

Control group: Patients in whom all fragments resulting from laser lithotripsy of ureteral stones were actively retrieved

Procedure: Ureteroscopy, Holmium Laser lithotripsy and active retrieval of fragments

Outcome Measures

Primary Outcome Measures

  1. unplanned medical visits [30 days]

Secondary Outcome Measures

  1. Hospital Admissions, need for pain killers, time to complete recovery [60 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient with ureteral stones suitable for endoscopic treatment
Exclusion Criteria:
  • presence of ipsilateral kidney stones

  • known ureteral stricture

  • previous placement of ureteral stent

  • use of drugs with known activity on smooth ureteral muscle

  • unwillingness or impossibility to return for follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Chaim Sheba Medical Center Tel Hashomer Ramat Gan Israel 52621

Sponsors and Collaborators

  • The Chaim Sheba Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00637650
Other Study ID Numbers:
  • 4638
First Posted:
Mar 18, 2008
Last Update Posted:
Feb 10, 2009
Last Verified:
Feb 1, 2009
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2009